
Moderna, Inc.
MRNAHealthcare|Biotechnology|US
$254.19
+12.73 (+5.27%)
Tangible Book / Share
$17.05
Cash / Share
$12.90
Next Earnings Report
Feb 12, 2027
EPS est. -$1.73 · Revenue est. $675.4M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Lost Money on Moderna, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 23.07% Share Price Drop
Oct 23, 2026 · Business Wire
Did You Lose Money on Moderna, Inc. Stock? The Law Offices of Howard G.
Oct 23, 2026 · Business Wire
Moderna Named a Top Employer by Science for Twelfth Consecutive Year
Oct 23, 2026 · Accesswire
Lost Money on Moderna, Inc. Shares? The Law Offices of Frank R.
Oct 22, 2026 · Business Wire
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
Oct 22, 2026 · Business Wire
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
Oct 13, 2026 · Accesswire
Tempus Announces Multi-Year Collaboration with Moderna and Merck
Oct 7, 2026 · Business Wire
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
Oct 1, 2026 · GlobeNewsWire
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Sep 30, 2026 · Accesswire
Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
Sep 21, 2026 · Accesswire
SEC Filings (61)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2026 | 8-K | Material event | DocumentIndex |
| Nov 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 30, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 31, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 24, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 8, 2026 | 8-K | Material event | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| May 1, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 1, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 16, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 16, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 16, 2026 | ARS | Annual report to holders | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 20, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Feb 20, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 13, 2026 | 8-K | Material event | DocumentIndex |
| Feb 11, 2026 | 8-K | Material event | DocumentIndex |
| Feb 9, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | 8-K | Material event | DocumentIndex |
| Dec 16, 2025 | SC TO-I/A | Tender offer | DocumentIndex |
| Nov 24, 2025 | 8-K | Material event | DocumentIndex |
| Nov 20, 2025 | 8-K | Material event | DocumentIndex |
| Nov 18, 2025 | SC TO-I/A | Tender offer | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | SC TO-I | Tender offer | DocumentIndex |
| Nov 12, 2025 | SC TO-C | Tender offer | DocumentIndex |
| Nov 6, 2025 | SC TO-C | Tender offer | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Nov 5, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |